Ad-hoc | 4 August 2004 07:27

Fresenius Group – First half of 2004

Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– Fresenius Group – First half of 2004 Fresenius raises sales and earnings outlook Fresenius Group’s revenue and earnings development in the first half 2004 was very successful: Sales rose 9 % in constant currency. At actual exchange rates sales increased 3 % to EUR 3,553 million (first half 2003: EUR 3,456 million). Group EBIT increased 13 % in constant currency and 6 % at actual exchange rates to EUR 412 million (first half 2003: EUR 390 million). Net income rose 21 % in constant currency to EUR 80 million and 14 % at actual exchange rates (first half 2003: EUR 70 million). Earnings per ordinary share rose to EUR 1.95 (first half 2003: EUR 1.70). Earnings per preference share rose to EUR 1.97 (first half 2003: EUR 1.72). This represents an increase of 14 %. Based on the excellent results at Fresenius Medical Care and Fresenius Kabi the Company raises its full-year outlook: Fresenius now expects a high single-digit percent increase in sales in constant currency. Previously, the Company expected a mid-single digit percent increase in sales. Net income is expected to grow approximately 30 % in constant currency. Previously, the Company expected net income to grow at 25-30 %. Sales and earnings growth is expected in all business segments. The Management Board Bad Homburg v.d.H., August 4, 2004 end of ad-hoc-announcement (c)DGAP 04.08.2004 ——————————————————————————– WKN: 578563; ISIN: DE0005785638; Index: MDAX Listed: Amtlicher Markt in Düsseldorf, Frankfurt (Prime Standard) und München; Freiverkehr in Berlin-Bremen, Hamburg und Stuttgart 040727 Aug 04